Stock Events

Stock Events

Allogene Therapeutics (ALLO) Q2 2024 Earnings

13MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.59

-0.52

-0.44

-0.37

Details

Expected EPS

-0.409587

Actual EPS

-0.38

Surprise EPS

0.03

Surprise Percent

+7.22%

Description

Allogene Therapeutics (ALLO) has reported earnings of -0.38 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.